GURUFOCUS.COM » STOCK LIST » Industrials » Construction » Exponent Inc (NAS:EXPO) » Definitions » Sloan Ratio %

Exponent (Exponent) Sloan Ratio % : -1.65% (As of Dec. 2023)


View and export this data going back to 1985. Start your Free Trial

What is Exponent Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Exponent's Sloan Ratio for the quarter that ended in Dec. 2023 was -1.65%.

As of Dec. 2023, Exponent has a Sloan Ratio of -1.65%, indicating the company is in the safe zone and there is no funny business with accruals.


Exponent Sloan Ratio % Historical Data

The historical data trend for Exponent's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exponent Sloan Ratio % Chart

Exponent Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.30 -4.44 -9.00 3.51 -1.65

Exponent Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.51 4.15 2.52 3.76 -1.65

Competitive Comparison of Exponent's Sloan Ratio %

For the Engineering & Construction subindustry, Exponent's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Exponent's Sloan Ratio % Distribution in the Construction Industry

For the Construction industry and Industrials sector, Exponent's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Exponent's Sloan Ratio % falls into.



Exponent Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Exponent's Sloan Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2023 )-Cash Flow from Operations (A: Dec. 2023 )
-Cash Flow from Investing (A: Dec. 2023 ))/Total Assets (A: Dec. 2023 )
=(100.339-127.352
--16.356)/646.777
=-1.65%

Exponent's Sloan Ratio for the quarter that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Dec. 2023 )
=(100.339-127.352
--16.356)/646.777
=-1.65%

Exponent's Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was 29.124 (Mar. 2023 ) + 25.748 (Jun. 2023 ) + 24.538 (Sep. 2023 ) + 20.929 (Dec. 2023 ) = $100.3 Mil.
Exponent's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 was -6.703 (Mar. 2023 ) + 40.545 (Jun. 2023 ) + 22.201 (Sep. 2023 ) + 71.309 (Dec. 2023 ) = $127.4 Mil.
Exponent's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2023 was -5.668 (Mar. 2023 ) + -5.448 (Jun. 2023 ) + -3.306 (Sep. 2023 ) + -1.934 (Dec. 2023 ) = $-16.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Exponent  (NAS:EXPO) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Dec. 2023, Exponent has a Sloan Ratio of -1.65%, indicating the company is in the safe zone and there is no funny business with accruals.


Exponent Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Exponent's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Exponent (Exponent) Business Description

Traded in Other Exchanges
Address
149 Commonwealth Drive, Menlo Park, CA, USA, 94025
Exponent Inc provides engineering and scientific consulting services on a project-by-project basis. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which accounts for the majority of revenue, provides servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.
Executives
Reitman Maureen T. F. officer: Group Vice President 149 COMMONWEALTH DRIVE, MENLO PARK CA 94025
Bradley A James officer: Group Vice President 149 COMMONWEALTH DRIVE, MENLO PARK CA 94025
Steven J Murray officer: Group Vice President 149 COMMONWEALTH DRIVE, MENLO PARK CA 94025
Richard Reiss officer: Group Vice President 149 COMMONWEALTH DRIVE, MENLO PARK CA 94025
Joseph Rakow officer: Group Vice President 149 COMMONWEATH DRIVE, MENLO PARK CA 94025
Eric Guyer officer: Group Vice Presient 149 COMMONWEALTH DRIVE, MENLO PARK CA 94025
Harri Kytomaa officer: Group Vice President 149 COMMONWEALTH DRIVE, MENLO PARK CA 94025
Carol Lindstrom director 5994 SILVERADO TRAIL, NAPA CA 94558
Sally Shepard officer: VP, Human Resources 149 COMMONWEALTH DRIVE, MENLO PARK CA 94025
George H. Brown director 149 COMMONWEALTH DRIVE, MENLO PARK CA 94025
Paul R Johnston officer: Chief Operating Officer EXPONENT INC, 149 COMMONWEALTH DRIVE, MENLO PARK CA 94025
John Joseph Doyle officer: Group Vice President 149 COMMONWEALTH DRIVE, MENLO PARK CA 94025
Schlenker Richard L Jr officer: Chief Financial Officer EPONENT INC, 149 COMMONWEALTH DRIVE, MENLO PARK CA 94025
John Pye officer: Group Vice President 149 COMMONWEALTH DRIVE, MENLO PARK CA 94025
Debra Zumwalt director 149 COMMONWEALTH DRIVE, MENLO PARK CA 94025

Exponent (Exponent) Headlines